PLIANT THERAPEUTICS
Live / Registered — Registered — Sections 8 & 15 accepted and acknowledged (as of 08 Dec 2025)
What this means for you
Registered since 27 Aug 2019. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Aug 2029: the §8 & §9 renewal).
Record
- Serial number
- 86860144
- Registration number
- 5845814
- Mark type
- Word mark
- Filed
- 29 Dec 2015
- Published for opposition
- 24 May 2016
- Registered
- 27 Aug 2019
- Next maintenance filing
- §8 & §9 renewal, due by 27 Aug 2029 (grace period to 27 Feb 2030)
- Attorney of record
- Joyce Liou
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for use in the treatment of fibrotic diseases, inflammatory diseases
Owner
- Pliant Therapeutics, Inc., South San Francisco, CA, US
- Pliant Therapeutics, Inc., Redwood City, CA, US
- Pliant Therapeutics, Inc., Redwood City, CA, US
Prosecution history
- 08 Dec 2025 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 08 Dec 2025 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 08 Dec 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 27 Aug 2025 — TEAS SECTION 8 & 15 RECEIVED
- 24 Jun 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 24 Jun 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 24 Jun 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 24 Jun 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 24 Jun 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 27 Aug 2024 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 27 Aug 2019 — REGISTERED-PRINCIPAL REGISTER
- 25 Jul 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 24 Jul 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 22 Jul 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 19 Jul 2019 — USE AMENDMENT FILED